PMN – promis neurosciences inc. - common shares (US:NASDAQ)
Stock Stats
News
Promis Neurosciences (NASDAQ:PMN) was downgraded by analysts at Wall Stre
Promis Neurosciences (NASDAQ:PMN) had its price target lowered by analysts at Guggenheim from $125.00 to $35.00. They now have a "buy" rating on the stock.
ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 [Canadian Business Journal (Canada)]
ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
ProMIS Neurosciences Announces Up to $175 Million Private Placement Financing
Form 4 ProMIS Neurosciences For: Mar 05 Filed by: Williams Eugene
Form 4 ProMIS Neurosciences For: Mar 02 Filed by: Williams Eugene
Form 3 ProMIS Neurosciences For: Feb 03 Filed by: ABG Global Life Science Capital Partners V GP Ltd
Form 4 ProMIS Neurosciences For: Feb 19 Filed by: Kaplan Johanne
Form SCHEDULE 13G/A ProMIS Neurosciences Filed by: ARMISTICE CAPITAL, LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.